May 03, 2009 | Injection Treatments
New Wrinkle Blocker Dysport Gets FDA Clearance

A new Botox competitor from Ipsen and Medicis Pharmaceutical has received FDA approval for treating wrinkles and dystonia. Plastic surgeons and dermatologists may have the drug available for cosmetic use in just 30 – 60 days. Rather than rebranding the drug ‘Reloxin’ as planned, Medicis decided to retain its original European name, Dysport The April […]
Read More